Ryan Specialty (NYSE:RYAN) Issues Quarterly Earnings Results, Beats Expectations By $0.14 EPS

Ryan Specialty (NYSE:RYAN) issued its earnings results on Thursday. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.60 by $0.14, FiscalAI reports. The business had revenue of $916.65 million during the quarter, compared to analysts’ expectations of $873.93 million. Ryan Specialty had a net margin of 7.55% and a return on equity of 42.02%. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.66 EPS.

Here are the key takeaways from Ryan Specialty’s conference call:

• Second-quarter results exceeded expectations, with revenue up 7.2% to $917 million, organic growth of 6.7%, adjusted EBITDA up 6% to $327 million, and adjusted EPS up 12.1% to $0.74. First-half organic growth reached 8.9%, while management raised its full-year organic growth outlook to the higher end of the mid-single-digit range.
• Ryan Specialty repurchased 8.1 million shares for $260 million during the quarter, authorized an additional $300 million for buybacks, and repurchased another $42 million in July. Net leverage ended at 3.3 times, within management’s targeted 3-to-4-times range.
• The company expects continued pressure from declining property pricing, heightened competition in casualty and binding authority, builders-risk headwinds, and a difficult third-quarter comparison. Full-year adjusted EBITDA margin is now expected to decline approximately 50 to 100 basis points, reflecting talent investments, lower fiduciary income, and higher healthcare costs.
• Management highlighted strong performance in casualty construction, professional lines, transactional liability, and reinsurance, supported by a robust pipeline and continued specialty-market demand. Investments in AI, alternative capital solutions, benefits, and new underwriting businesses are intended to improve productivity, diversify revenue, and support longer-term growth.
• Management said it is unlikely to close a meaningful acquisition in 2026 and is instead evaluating opportunities for 2027, while maintaining a disciplined approach focused on strategic fit, cultural alignment, and accretion.

Ryan Specialty Stock Performance

Ryan Specialty stock traded up $0.17 during midday trading on Friday, reaching $44.26. 3,717,920 shares of the stock traded hands, compared to its average volume of 1,930,806. The firm has a fifty day moving average price of $37.74 and a two-hundred day moving average price of $38.43. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 2.90. The firm has a market cap of $11.67 billion, a price-to-earnings ratio of 61.47, a PEG ratio of 0.96 and a beta of 0.61. Ryan Specialty has a fifty-two week low of $29.28 and a fifty-two week high of $61.85.

Ryan Specialty Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 25th. Investors of record on Tuesday, August 11th will be issued a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, August 11th. Ryan Specialty’s dividend payout ratio (DPR) is 67.53%.

Key Stories Impacting Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Second-quarter revenue rose 7.2% year over year to $916.6 million, exceeding the $873.9 million analyst consensus. Adjusted earnings of $0.74 per share also surpassed estimates of approximately $0.60–$0.61 and increased from $0.66 a year earlier. Ryan Specialty Reports Second Quarter 2026 Results
• Positive Sentiment: Management guided 2026 organic revenue growth toward the higher end of its mid-single-digit range, reinforcing expectations for continued expansion. Keefe, Bruyette & Woods raised its price target from $48 to $54 and upgraded or maintained an “outperform” rating, signaling increased confidence in the company’s outlook. Ryan Specialty 2026 Guidance
• Positive Sentiment: Ryan Specialty declared a quarterly dividend of $0.13 per share, equivalent to $0.52 annually and an approximately 1.1% yield. The payout adds shareholder returns, although the dividend is not the primary earnings catalyst.
• Neutral Sentiment: The earnings beat prompted broader analyst estimate increases and helped drive a sharp post-results advance in the stock. However, shares trade at a relatively elevated valuation, with a reported P/E ratio above 57, leaving the stock sensitive to any slowdown in growth or profitability.
• Negative Sentiment: Organic revenue growth moderated to 6.7% from 7.1% a year earlier, while management expects the 2026 adjusted EBITDAC margin to decline by 50–100 basis points. Reports also noted that the excess-and-surplus insurance market is slowing, creating a risk to future growth and margins. Ryan Specialty Q2 Revenue and E&S Market

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, EVP Mark Stephen Katz acquired 3,215 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were bought at an average price of $31.07 per share, with a total value of $99,890.05. Following the purchase, the executive vice president directly owned 4,332 shares of the company’s stock, valued at approximately $134,595.24. This trade represents a 287.82% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director John W. Rogers, Jr. acquired 7,500 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were bought at an average price of $35.16 per share, with a total value of $263,700.00. Following the transaction, the director directly owned 117,933 shares in the company, valued at approximately $4,146,524.28. The trade was a 6.79% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have purchased 130,715 shares of company stock valued at $4,263,590. Company insiders own 52.03% of the company’s stock.

Institutional Investors Weigh In On Ryan Specialty

Several hedge funds have recently made changes to their positions in RYAN. Los Angeles Capital Management LLC purchased a new stake in Ryan Specialty in the 4th quarter worth approximately $25,000. Advisory Services Network LLC bought a new position in shares of Ryan Specialty during the 3rd quarter worth about $28,000. Quarry LP bought a new stake in shares of Ryan Specialty during the third quarter valued at approximately $37,000. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Ryan Specialty by 173.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company’s stock worth $37,000 after acquiring an additional 450 shares during the period. Finally, GW&K Investment Management LLC boosted its stake in Ryan Specialty by 77.0% in the 4th quarter. GW&K Investment Management LLC now owns 876 shares of the company’s stock valued at $45,000 after buying an additional 381 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on RYAN shares. Morgan Stanley lifted their target price on Ryan Specialty from $39.00 to $42.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. The Goldman Sachs Group increased their price objective on shares of Ryan Specialty from $40.00 to $45.00 and gave the company a “neutral” rating in a research note on Friday. Barclays upped their target price on shares of Ryan Specialty from $46.00 to $48.00 and gave the company an “overweight” rating in a report on Friday. Citigroup decreased their target price on shares of Ryan Specialty from $55.00 to $50.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Finally, Mizuho lifted their price objective on Ryan Specialty from $39.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday. Eight investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $52.00.

Ryan Specialty declared that its board has initiated a share repurchase plan on Tuesday, May 26th that permits the company to buyback $300.00 million in shares. This buyback authorization permits the company to purchase up to 3.5% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.